Hemophagocytic Lymphohistiocytosis Complicated by Acute Respiratory Distress Syndrome and Multiorgan Failure

J Investig Med High Impact Case Rep. 2021 Jan-Dec:9:23247096211052180. doi: 10.1177/23247096211052180.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition that is characterized by an overactive response of the immune system with excessive production of proinflammatory cytokines. Initial presentation of this condition often mimics and overlaps with many diseases including infections, sepsis, and multiorgan failure syndrome, which makes diagnosis the diagnosis of HLH challenging. Herein is described a case of a patient who developed acute respiratory distress syndrome and multiple organ failure related to HLH in a setting of probable viral pneumonia. The diagnosis was established based on laboratory and bone marrow biopsy findings. This patient was treated with the standard chemotherapy regimen of intravenous dexamethasone, etoposide in addition to intrathecal methotrexate for central nervous system involvement.

Keywords: acute respiratory distress syndrome; hematology oncology; hemophagocytic lymphohistiocytosis; multiorgan failure; pulmonary critical care.

Publication types

  • Case Reports

MeSH terms

  • Etoposide
  • Humans
  • Lymphohistiocytosis, Hemophagocytic* / complications
  • Lymphohistiocytosis, Hemophagocytic* / diagnosis
  • Lymphohistiocytosis, Hemophagocytic* / drug therapy
  • Methotrexate
  • Multiple Organ Failure / etiology
  • Respiratory Distress Syndrome* / drug therapy
  • Respiratory Distress Syndrome* / etiology

Substances

  • Etoposide
  • Methotrexate